Evidence map›Paper›PMID 42757222›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2026

A case of tic improvement following tipepidine administration in a boy with Tourette syndrome comorbid with attention-deficit/hyperactivity disorder and autism spectrum disorder.

Masumi Tachibana, Tsuyoshi Sasaki

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Masumi TachibanaSafety and Health Organization Chiba University Chiba Japan.ORCID https://orcid.org/0000-0003-1040-3957
Tsuyoshi SasakiDepartment of Psychiatry Chiba University Graduate School of Medicine Chiba Japan.ORCID https://orcid.org/0000-0001-8502-6469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tourette Syndrome (TS) is defined by motor and vocal tics that begin in childhood and persist for over a year. TS causes difficulties in daily life and lowers self-esteem, yet pharmacological treatment options for TS remain limited. Tipepidine, administered in this case report, is generally used as a safe and inexpensive cough suppressant. Recent studies have suggested that tipepidine may improve symptoms of attention-deficit/hyperactivity disorder (ADHD) and depression. Case Presentation: We report the clinical course of a boy with TS, ADHD, and autism spectrum disorder (ASD), in whom the addition of tipepidine to aripiprazole was associated with improvement in both motor and vocal tics. The patient had tried several antipsychotics before he was prescribed tipepidine. However, the effectiveness of those drugs was temporary, and the patient experienced tolerability issues such as drowsiness. The addition of tipepidine was well tolerated, and the improvement in tic symptoms was maintained during long-term follow-up. Conclusion: This case suggests that adjunctive tipepidine may be well tolerated and associated with sustained improvement in motor and vocal tics during long-term follow-up in a patient with TS receiving aripiprazole.

Indexed as

motor ticstipepidineTourette syndromevocal tics

Identifiers

PMID42757222
PMCPMC13584892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.